Table 1. Baseline Demographic and Clinical Characteristics of Patientsa.
| Characteristic | Patients (N = 78) | RA group (n = 40) | SA group (n = 38) | P value |
|---|---|---|---|---|
| Age, mean (SD), y | 64.1 (7.9) | 64.4 (7.5) | 63.8 (8.5) | .75 |
| Sex | ||||
| Male | 41 (52.6) | 23 (57.5) | 18 (47.4) | .37 |
| Female | 37 (47.4) | 17 (42.5) | 20 (52.6) | |
| Alcohol consumption history | ||||
| Yes | 20 (25.6) | 11 (27.5) | 9 (23.7) | .52 |
| No | 58 (74.4) | 29 (72.5) | 29 (76.3) | |
| Smoking history | ||||
| Yes | 20 (25.6) | 9 (22.5) | 11 (28.9) | .70 |
| No | 58 (74.4) | 31 (77.5) | 27 (71.1) | |
| PD severity by modified Hoehn and Yahr stage | ||||
| <2.5 | 54 (69.2) | 29 (72.5) | 25 (65.8) | |
| 2.5 | 12 (15.4) | 7 (17.5) | 5 (13.2) | |
| 3 | 12 (15.4) | 4 (10.0) | 8 (15.4) | |
| Levodopa equivalent dose, mean (SD), mg/d | 613.6 (326.0) | 621.3 (361.1) | 605.6 (289.1) | .83 |
| Duration of PD, mean (SD), y | 7.2 (4.9) | 7.9 (5.7) | 6.5 (3.8) | .21 |
| Score on outcome measure, mean (SD) | ||||
| PDSS | 85.3 (19.0) | 85.6 (3.1) | 85.0 (3.0) | .90 |
| Sleep quality rating | ||||
| 0-60 | 42 (53.8) | 22 (55.0) | 20 (52.6) | NA |
| 61-90 | 24 (30.8) | 12 (31.6) | 12 (31.6) | NA |
| 91-110 | 12 (15.4) | 6 (15.8) | 6 (15.8) | NA |
| ESS | 8.7 (5.7) | 8.8 (0.9) | 8.6 (1.0) | .85 |
| UPDRS | 44.3 (20.2) | 44.2 (2.7) | 44.4 (3.8) | .97 |
| UPDRS-III | 24.8 (11.7) | 24.7 (1.7) | 24.8 (2.1) | .97 |
| NMSS | 39.8 (18.6) | 39.5 (2.2) | 40.1 (3.7) | .87 |
| HAM-A | 14.3 (6.2) | 13.9 (1.0) | 14.6 (1.0) | .53 |
| PDQ-39 | 38.6 (17.1) | 39.2 (3.1) | 38 (2.3) | .71 |
Abbreviations: ESS, Epworth Sleepiness Scale; HAM-A, Hamilton Anxiety Rating Scale; NA, not applicable; NMSS, Non-Motor Symptoms Scale; PD, Parkinson Disease; PDQ-39, 39-item Parkinson Disease Questionnaire; PDSS, Parkinson Disease Sleep Scale; RA, real acupuncture; SA, sham acupuncture; UPDRS, Unified Parkinson Disease Rating Scale; UPDRS-III, section 3 of the Unified Parkinson Disease Rating Scale.
a
Unless indicated otherwise, values are presented as No. (%) of patients.